Explore PACK EXPO insights here
Discover a taste of the PACK EXPO highlights, live from the show floor!

GSK Recalls 600,000 Ventolin Inhalers

A manufacturing glitch at GSK’s North Carolina facility caused Ventolin inhalers to be made with a defective delivery system.

GSK Facility in London / Image: Maxwell Hamilton
GSK Facility in London / Image: Maxwell Hamilton

An inhaler’s sole purpose is to deliver a specific dose of medicine, but when that delivery system isn’t functioning properly, the consequences are costly. A recent FiercePharma article noted GlaxoSmithKline’s voluntary recall of nearly 600,000 Ventolin inhalers used to treat asthma and acute bronchitis. The recall was prompted by the discovery that a number of units were out of specification for leak rate at GSK’s facility in Zebulon, North Carolina.

A spokesperson from GSK noted it is not a consumer-level recall, so patients who have Ventolin inhalers on hand are safe. However, products in the retail and wholesale channels are being removed. Last year, GSK recalled 130,000 inhalers because the canisters didn’t contain enough propellant to deliver the 200 doses the label claimed to provide through the end of its shelf life.

Annual Outlook Report: Automation & Robotics
What's in store for CPGs in 2025 and beyond? Packaging World editors explore the survey responses from 118 brand owners, CPG, and FMCG Packaging World readers for its new Annual Outlook Report.
Download
Annual Outlook Report: Automation & Robotics
Annual Outlook Report: Workforce
Hiring remains a major challenge in packaging, with 78% struggling to fill unskilled roles and 84% lacking experienced workers. As automation grows, companies must rethink hiring and training. Download the full report for key insights.
Download Now
Annual Outlook Report: Workforce